The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology
Abstract
The French health care system is based on universal coverage by one of several health care insurance plans. The SNIIRAM database merges anonymous information of reimbursed claims from all these plans, linked to the national hospital‐discharge summaries database system (PMSI) and the national death registry. It now covers 98.8% of the French population, over 66 million persons, from birth (or immigration) to death (or emigration), making it possibly the world's largest continuous homogeneous claims database. The database includes demographic data; health care encounters such as physician or paramedical visits, medicines, medical devices, and lab tests (without results); chronic medical conditions (ICD10 codes); hospitalisations with ICD10 codes for primary, linked and associated diagnoses, date and duration, procedures, diagnostic‐related groups, and cost coding; date but currently not cause of death. The power of the database is correlatively great, and its representativeness is near perfect, since it essentially includes the whole country's population. The main difficulty in using the database, beyond its sheer size and complexity, is the administrative process necessary to access it. Recent legislative advances are making this easier. EGB (Echantillon Généraliste de Bénéficiaires) is the 1/97th random permanent representative sample of SNIIRAM, with planned 20‐year longitudinal data (10 years at this time). Access time is 1 to 3 months, but its power is less (780 000 subjects). This is enough to study common issues with older drugs but may be limited for new products or rare events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667 · cited 1×
“In addition to claims, databases there are electronic health records (EHR), such as the clinical practice research datalink (CPRD) in the United Kingdom, which contains medical records, including signs and symptoms, or the results of biological tests.(63) They provide different information from the claims databases, a…”
BackgroundFrench national health insurance information system and the permanent beneficiaries sample
Tuppin, P., de Roquefeuil, L., Weill, A., Ricordeau, P., & Merlière, Y. (2010) · Revue d'Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2010.04.005 · Cited by 399
French health insurance databases: What interest for medical research?
Moulis, G., Lapeyre-Mestre, M., Palmaro, A., Pugnet, G., Montastruc, J.-L., & Sailler, L. (2015) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2014.11.009 · Cited by 363
The U.S. Food and Drug Administration's Mini‐Sentinel program: status and direction
Platt, R., Carnahan, R. M., Brown, J. S., Chrischilles, E., Curtis, L. H., Hennessy, S., Nelson, J. C., Racoosin, J. A., Robb, M., Schneeweiss, S., et al. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2343 · Cited by 287
Neumann, A., Weill, A., Ricordeau, P., Fagot, J. P., Alla, F., & Allemand, H. (2012) · Diabetologia · doi:10.1007/s00125-012-2538-9 · Cited by 284
Coloma, P. M., Schuemie, M. J., Trifirò, G., Gini, R., Herings, R., Hippisley‐Cox, J., Mazzaglia, G., Giaquinto, C., Corrao, G., Pedersen, L., et al. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2053 · Cited by 259
Weill, A., Dalichampt, M., Raguideau, F., Ricordeau, P., Blotière, P.-O., Rudant, J., Alla, F., & Zureik, M. (2016) · BMJ · doi:10.1136/bmj.i2002 · Cited by 208
Maura, G., Blotière, P.-O., Bouillon, K., Billionnet, C., Ricordeau, P., Alla, F., & Zureik, M. (2015) · Circulation · doi:10.1161/circulationaha.115.015710 · Cited by 174
CNODES: the Canadian Network for Observational Drug Effect Studies.
Suissa, S., Henry, D. A., Caetano, P. A., Dormuth, C. R., Ernst, P., Hemmelgarn, B. R., LeLorier, J., Levy, A. R., Martens, P. J., Paterson, J. M., et al. (2012) · Europe PMC (PubMed Central) · Cited by 162
Defining a Reference Set to Support Methodological Research in Drug Safety
Ryan, P. B., Schuemie, M. J., Welebob, E. M., Duke, J. D., Valentine, S., & Hartzema, A. G. (2013) · Drug Safety · doi:10.1007/s40264-013-0097-8 · Cited by 151
Cited by
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
Bezin, J., Gouverneur, A., Pénichon, M., Mathieu, C., Garrel, R., Hillaire-Buys, D., Pariente, A., & Faillie, J.-L. (2023) · Diabetes Care · doi:10.2337/dc22-1148 · Cited by 320
Self-citationRoussel, R., Riveline, J.-P., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2021) · Diabetes Care · doi:10.2337/dc20-1690 · Cited by 173
Big data in IBD: a look into the future
Olivera, P., Danese, S., Jay, N., Natoli, G., & Peyrin-Biroulet, L. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0102-5 · Cited by 151
Riveline, J.-P., Roussel, R., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0085 · Cited by 64
Tournier, M., Bénard‐Laribière, A., Jollant, F., Hucteau, E., Diop, P., Jarne‐Munoz, A., Pariente, A., Oger, E., & Bezin, J. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13582 · Cited by 35
Self-citation
Metadata
- Authors
- Bezin, J., Duong, M., Lassalle, R., Droz, C., Pariente, A., Blin, P., & Moore, N.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2017-05-24
- Volume
- 26
- Issue
- 8
- Pages
- 954-962
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2617556060
- Cited by
- 584
- References
- 49
- FWCI
- 96.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology. https://app.cochat.ai/papers/10.1002/pds.4233
- The paper
- Bezin, J., Duong, M., Lassalle, R., Droz, C., Pariente, A., Blin, P., & Moore, N. (2017). The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.4233
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.